Figure 2.
Change from baseline in the number of CSBMs per week (wk 1-4) by treatment (ITT population). Footnote: bP = 0.0002 vs placebo; Mean number of CSBMs per week at baseline: tegaserod 0.36; placebo 0.31.
Change from baseline in the number of CSBMs per week (wk 1-4) by treatment (ITT population). Footnote: bP = 0.0002 vs placebo; Mean number of CSBMs per week at baseline: tegaserod 0.36; placebo 0.31.